Preclinical characterization and phase 1 clinical testing of targeting mitochondrial peroxiredoxin 3 in cancer
- Victoria Gibson
- Joanna Dzialo
- Terri Messier
- Aleksandra Bzura
- Charlotte Poile
- Jan Rogel
- Jens C. Hahne
- Aida Habibovic
- Stephanie Stead
- Alexis Saaman
- Kevin G. Blyth
- Peter W. Szlosarek
- Simon Lord
- Fiona Thistlethwaite
- Min Zhang
- Apostolos Nakas
- Peter Wells-Jordan
- Kudzayi Kutywayo
- Kelly J. Butnor
- Nicholas. H. Heintz
- George N. Naumov
- Maurice Dungey
- Julio Herrero Colomina
- Burak Aktas
- Sean Dulloo
- James Spicer
- Dean A. Fennell
- Brian Cunniff
2026-07-14